According to recent filings covering the 90 days ending December 12, 2025, the three most significant insider holders at Ligand Pharmaceuticals are Chief Executive Officer Todd C Davis (161.34K shares), Director Jason Aryeh (71.32K shares), Director John W Kozarich (44.12K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| John L Higgins | 417,695 | 30 Dec, 2022 | |
| Matthew W Foehr | 162,187 | 03 Nov, 2022 | |
| Todd C Davis | Chief Executive Officer | 161,337 | 08 Dec, 2025 |
| Jason Aryeh | 71,323 | 08 Dec, 2025 | |
| Matthew E Korenberg | President & COO | 50,777 | 24 Sep, 2024 |
| John W Kozarich | 44,121 | 03 Dec, 2025 | |
| Stephen L Sabba | 33,793 | 10 Jun, 2025 | |
| Andrew Reardon | Clo & Secretary | 30,811 | 12 Aug, 2025 |
| John L Lamattina | 30,724 | 12 Nov, 2025 | |
| Sunil Patel | 28,820 | 03 Nov, 2022 | |
| Octavio Espinoza | Chief Financial Officer | 27,990 | 09 Dec, 2025 |
| Charles S Berkman | 23,825 | 03 Nov, 2022 | |
| Nancy Ryan Gray | 8,094 | 12 Nov, 2025 | |
| Jason Haas | 6,606 | 10 Jun, 2025 | |
| Martine Zimmermann | 4,443 | 24 Sep, 2025 | |
| Sarah Boyce | 2,892 | 03 Nov, 2022 | |
| Jennifer R. Cochran | 1,161 | 03 Nov, 2022 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 08 Dec, 2025 | Jason Aryeh | Common Stock | A | 2,034 | $69.51 | 71,323 | D | M |
| 05 Dec, 2025 | Octavio Espinoza | Common Stock | D | 1,862 | $184.87 | 27,990 | D | F |
| 04 Dec, 2025 | Todd C Davis | Common Stock | D | 130 | $0.00 | 161,337 | D | G |
| 01 Dec, 2025 | John W Kozarich | Common Stock | D | 92 | $193.86 | 44,496 | D | S |
| 01 Dec, 2025 | John W Kozarich | Common Stock | D | 179 | $194.76 | 44,317 | D | S |
| 01 Dec, 2025 | John W Kozarich | Common Stock | D | 47 | $195.80 | 44,270 | D | S |
| 01 Dec, 2025 | John W Kozarich | Common Stock | D | 4 | $196.34 | 44,266 | D | S |
| 01 Dec, 2025 | John W Kozarich | Common Stock | D | 92 | $197.72 | 44,174 | D | S |
| 01 Dec, 2025 | John W Kozarich | Common Stock | D | 23 | $199.22 | 44,151 | D | S |
| 01 Dec, 2025 | John W Kozarich | Common Stock | D | 30 | $200.02 | 44,121 | D | S |
| 07 Nov, 2025 | John L Lamattina | Common Stock | A | 2,145 | $66.13 | 32,869 | D | M |
| 07 Nov, 2025 | Nancy Ryan Gray | Common Stock | A | 3,556 | $66.19 | 11,650 | D | M |
| 07 Nov, 2025 | Nancy Ryan Gray | Common Stock | D | 3,556 | $205.45 | 8,094 | D | S |
| 07 Nov, 2025 | John L Lamattina | Common Stock | D | 2,145 | $205.45 | 30,724 | D | S |
| 07 Nov, 2025 | Nancy Ryan Gray | Common Stock | A | 3,015 | $73.57 | 11,109 | D | M |
| 07 Nov, 2025 | John L Lamattina | Common Stock | A | 2,034 | $69.51 | 32,758 | D | M |
| 07 Nov, 2025 | John L Lamattina | Common Stock | D | 2,034 | $205.45 | 30,724 | D | S |
| 07 Nov, 2025 | Nancy Ryan Gray | Common Stock | D | 3,015 | $205.45 | 8,094 | D | S |
| 03 Nov, 2025 | John W Kozarich | Common Stock | D | 84 | $189.00 | 44,971 | D | S |
| 03 Nov, 2025 | John W Kozarich | Common Stock | D | 49 | $190.26 | 44,922 | D | S |